103 related articles for article (PubMed ID: 7680956)
1. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM
Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956
[TBL] [Abstract][Full Text] [Related]
2. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
3. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
Krystal GW; Hines SJ; Organ CP
Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
[TBL] [Abstract][Full Text] [Related]
4. [A new strategy for treating small cell lung cancer].
Ueda R; Takashi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.
Hibi K; Takahashi T; Sekido Y; Ueda R; Hida T; Ariyoshi Y; Takagi H; Takahashi T
Oncogene; 1991 Dec; 6(12):2291-6. PubMed ID: 1722571
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene.
Berdel WE; de Vos S; Maurer J; Oberberg D; von Marschall Z; Schroeder JK; Li J; Ludwig WD; Kreuser ED; Thiel E
Cancer Res; 1992 Jun; 52(12):3498-502. PubMed ID: 1375870
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
[TBL] [Abstract][Full Text] [Related]
8. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.
Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE
Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
10. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
12. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
Krystal GW; DeBerry CS; Linnekin D; Litz J
Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
[TBL] [Abstract][Full Text] [Related]
13. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues.
Matsuda R; Takahashi T; Nakamura S; Sekido Y; Nishida K; Seto M; Seito T; Sugiura T; Ariyoshi Y; Takahashi T
Am J Pathol; 1993 Jan; 142(1):339-46. PubMed ID: 7678721
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
15. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
16. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of c-kit in small-cell lung cancer.
Hida T; Ueda R; Sekido Y; Hibi K; Matsuda R; Ariyoshi Y; Sugiura T; Takahashi T; Takahashi T
Int J Cancer Suppl; 1994; 8():108-9. PubMed ID: 7515024
[TBL] [Abstract][Full Text] [Related]
19. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
20. Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells.
Baghestanian M; Agis H; Bevec D; Bankl HC; Hofbauer R; Kress HG; Butterfield JH; Müller MR; Ashman LK; Füreder W; Willheim M; Lechner K; Valent P
Exp Hematol; 1996 Oct; 24(12):1377-86. PubMed ID: 8913283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]